These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12605568)
1. Treatment of scleroderma: an update. Sule SD; Wigley FM Expert Opin Investig Drugs; 2003 Mar; 12(3):471-82. PubMed ID: 12605568 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of systemic sclerosis]. van den Hoogen FH Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of scleroderma]. Mouthon L Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869 [TBL] [Abstract][Full Text] [Related]
4. [Long-term treatments for systemic sclerosis: what are the perspectives?]. Mouthon L; Agard C; Garcia De La Peña-Lefebvre P; Guillevin L Ann Med Interne (Paris); 2002 Jun; 153(4):265-75. PubMed ID: 12218893 [TBL] [Abstract][Full Text] [Related]
5. Drug treatment of scleroderma. Leighton C Drugs; 2001; 61(3):419-27. PubMed ID: 11293650 [TBL] [Abstract][Full Text] [Related]
7. [Evidence-based therapy of systemic sclerosis]. Genth E Z Rheumatol; 2001 Dec; 60(6):464-8. PubMed ID: 11826742 [TBL] [Abstract][Full Text] [Related]
8. Management of scleroderma. Winkelmann RK; Kierland RR; Perry HD; Muller SA; Sams WM Mayo Clin Proc; 1971 Feb; 46(2):128-34. PubMed ID: 5546412 [No Abstract] [Full Text] [Related]
9. Recent advances in the treatment of systemic sclerosis. Bournia VK; Vlachoyiannopoulos PG; Selmi C; Moutsopoulos HM; Gershwin ME Clin Rev Allergy Immunol; 2009 Jun; 36(2-3):176-200. PubMed ID: 19132559 [TBL] [Abstract][Full Text] [Related]
10. Novel investigational agents for the treatment of scleroderma. McMahan ZH; Wigley FM Expert Opin Investig Drugs; 2014 Feb; 23(2):183-98. PubMed ID: 24261610 [TBL] [Abstract][Full Text] [Related]
11. Treatment of scleroderma. Sapadin AN; Fleischmajer R Arch Dermatol; 2002 Jan; 138(1):99-105. PubMed ID: 11790173 [TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis. Vallance DK; Lynch JP; McCune WJ Curr Opin Rheumatol; 1995 May; 7(3):174-82. PubMed ID: 7612408 [TBL] [Abstract][Full Text] [Related]
13. [Advances in the treatment of scleroderma]. Marquet R; Vilardell M Med Clin (Barc); 1984 Jun; 83(2):74-7. PubMed ID: 6147448 [No Abstract] [Full Text] [Related]
14. Systemic sclerosis: an update. Varga J Bull NYU Hosp Jt Dis; 2008; 66(3):198-202. PubMed ID: 18937632 [TBL] [Abstract][Full Text] [Related]
15. Novel treatment approaches to fibrosis in scleroderma. Distler J; Distler O Rheum Dis Clin North Am; 2008 Feb; 34(1):145-59; vii. PubMed ID: 18329537 [TBL] [Abstract][Full Text] [Related]
16. [Systemic sclerosis : What is currently available for treatment?]. Becker MO Internist (Berl); 2016 Dec; 57(12):1155-1163. PubMed ID: 27796473 [TBL] [Abstract][Full Text] [Related]
17. Scleroderma therapy: clinical overview of current trends and future perspective. Topal AA; Dhurat RS Rheumatol Int; 2013 Jan; 33(1):1-18. PubMed ID: 23011088 [TBL] [Abstract][Full Text] [Related]